Clinical trial
Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage…
NCT00053339 · Alliance for Clinical Trials in Oncology, Other · Withdrawn
Key facts
| NCT number | NCT00053339 |
|---|---|
| Title | Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer |
| Official title | Phase III Randomized Study of Trastuzumab (Herceptin) With or Without Tamoxifen in Women With Progressive, Stage IV, Estrogen or Progesterone Receptor- and HER2/Neu-Positive Breast Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stage IV Breast Cancer, Recurrent Breast Cancer |
| Intervention type | Drug |
| Interventions | tamoxifen, trastuzumab |
| Enrollment | 0 |
| First posted | Jan 28, 2003 |
| Last update posted | Jul 12, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: